Study Group: Adderall XR Prescribers (US)(?)
Council Members in this Study Group: 79
Request a survey with this Study Group
Leading Experts in this Study Group
![]() |
What is a GLG Leader? |
Daniel Wynn, MDDirector, Clinical Research
Consultants In Neurology Ltd.
Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...
President
Red Oak Psychiatry Associates, P. A.
Lawrence Ginsberg, MD, is President and CEO of Red Oak Psychiatry Associates, PA, a multidisciplinary mental health group in Houston, Texas. Dr. Ginsberg's research interests include psychopharmacology, addiction medicine, and forensic psychiatry. His areas of clinical expertise are attention deficit...
Psychiatrist
Louis Sanfilippo, MD
Louis Sanfilippo, MD, is an Assistant Clinical Professor of Psychiatry at Yale School of Medicine and in private practice. He has served management and scientific advisory roles for Cenestra Health, a biotech company focused on developing empirically validated nutraceutical products. Dr. Sanfilippo...
Owner
Amit Vijapura, MD
Amit Vijapura, MD, is a Private Practitioner in Psychiatry based in Florida. He has over 15 years of experience in the field and has expertise in depression, bipolar disorder, anxiety disorder, attention deficient disorder, and schizophrenia. Dr. Vijapura is board certified in Psychiatry and is also...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Physicians who Treat ADHD (US) | 370 |
| Psychiatrists (US) | 1099 |
| Psychiatrists | 1428 |
| Prescribers of Strattera for ADHD | 67 |
| Physicians who Treat Schizophrenia (US) | 311 |
| Effexor XR Prescribers (US) | 137 |
| SSRI Prescribers (US) | 239 |
GLG NewsSMAnalyses by this Study Group's Experts(?)
‘One drug, many uses’ can make lots of sense clinically and commercially. Seeking additional FDA indications for a specific drug has obvious business benefits: greater revenue stream, improved branding, potentially longer market exclusivity, greater franchising potential of the drug...
Your mother and father will not get the compassion and care when they call for medical help . It will not be available. Your family physician was financially forced to leave.
Lundbeck has now disclosed the mechanism of action of its “mixed serotonin modulator and stimulator,” albeit buried in a first quarter report. Data on LuAA21004, Lundbeck’s lead antidepressant jointly in development with Takeda, was released at the Scandinavian College of Neuro-Psychopharmacology...
We need to look to the cause of why we prescribe antipsychotics to patients with dementia. We have very few tools to use and sometimes these drugs are a necessity.
This article clearly describes the Catch-22 in which most doctors, except for those employed by the large institutions, find themselves. We cannot afford to practice the "best" medicine, and yet, if we could, we might well make fewer errors and make medical care for our patients more seamless. ...
Most Common Company Types:
- Office Based Private Practice or Clinic
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Other Freestanding Healthcare Facility
- Academic Institution*
- Private/For-Profit Healthcare Research Entity
Most Common Job Types:
- Physician - Attending Physician
- Owner
- Physician - Director
- Director
- Physician - Division Head
- Partner
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms


